Sherri McLamb, PharmD, is a recent graduate of the Medical University of South Carolina who discovered her passion for medical communication during a rotation at PharmCon/FreeCE with Kevin Hope, RPh. With a background in patient care and a strong interest in public health education, Sherri enjoys transforming complex clinical topics into clear, practical insights that help pharmacy professionals deliver better care. Her professional interests include women’s health, health disparities, and promoting wellness through evidence-based education. Outside of pharmacy, Sherri is an avid fitness enthusiast who enjoys strength training, Pilates, and exploring new foods. She also loves reading and sharing knowledge that empowers others to live healthier lives.
A recent phase 2 clinical trial suggests that azelastine nasal spray, a common antihistamine used for allergic rhinitis, may reduce the risk of SARS CoV 2 infection. Researchers observed lower infection rates and fewer symptomatic cases among participants using the spray. Although these early findings are intriguing, larger studies are needed before azelastine can be recommended for routine COVID prevention.
If you already have a PharmCon freeCE account, click “Account Login” in the navigation bar.
Sign up to Pharmcon’s newsletter
to get exclusive discounts on
courses, study tools, and more!
